ÂÜÀòÂÒÂ×

Rachel Hunter, CPA has a strong background in finance and accounting. Rachel currently holds the position of Vice President Finance at Verona Pharma since July 2022. Prior to that, they served as the Controller at Istari Oncology from September 2020 to July 2022. Rachel also has experience as a Vice President Finance at Array Biostatistics from April 2020 to September 2020. Before shifting their career towards finance, they worked in various roles at Dova Pharmaceuticals, starting as an Assistant Controller from March 2018 to April 2019, and later as the Director of Finance from April 2019 to April 2020. Additionally, they worked as an Assistant Controller at Melinta Therapeutics from May 2017 to February 2018. Rachel's earlier work experience includes roles at Cempra Pharmaceuticals, where they served as an Associate Director in Accounting from January 2017 to April 2017, Accounting Manager from November 2014 to December 2016, and Senior Accountant from May 2012 to October 2014. Rachel began their career at Grant Thornton LLP, working as a Senior Audit Associate from October 2009 to November 2011.

Rachel Hunter, CPA completed their education at North Carolina State University - College of Management from 2004 to 2009, where they pursued a Masters in Accounting. In addition, they hold a certification as a Certified Public Accountant. No further information about the institution, month, or year of obtaining the certification is provided.